TGFBR1 and neoplasm: The frequency of TGFBR1*6A carriers among patients diagnosed with grade 3 tumours was higher than among patients diagnosed with grade 1 tumours (OR: 2.27; 95% CI: 1.01–5.11; P=0.049, Table 3).